Lv3
250 积分 2022-10-16 加入
Spironolactone vs Amiloride for Resistant Hypertension
4天前
已完结
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
12天前
已完结
DOACs for Superficial Vein Thrombosis: Risks of Pooling RCTs and Observational Studies in Comparative Effectiveness
1个月前
已完结
Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?*
1个月前
已完结
Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease
1个月前
已完结
Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients
2个月前
已完结
Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure
2个月前
已完结
Real-World Experience of Angiotensin Receptor-Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease
2个月前
已关闭
Community-acquired pneumonia
2个月前
已完结
Efficacy and safety of sacubitril-valsartan in hypertension patients with end-stage kidney disease on maintenance dialysis: a meta-analysis
3个月前
已完结
皖公网安备34019202002308
